NGSX will run to 5 dollar today .

Partnership and FDA news coming very soon 0STRONG BUY

RALLY will continue = TIME TO BUY MORE

Last chance to load up at 4 dollar .

RALLY TIME WILL START ANY MINUTE NOW

Strong buy on Stoxline
http://www.stoxline.com/quote.php?symbol=ngsx

Breakout coming

Consolidation creates a great buying opportunity .

Not many shares available under 4$ .

Load up before the stock start moving up fast which will happen very soon .

NGSX is moving back up... This stock will move up over the 200-Day Moving Average which is at $ 6.12 very soon .Anything below $5 is a pure gift .GLTA

MA50 = $ 4.66
MA200 = $6.12

Buy confirmed by Americanbulls
http://www.americanbulls.com/StockPage.asp?CompanyTicker=NGSX&MarketTicker=NASD&TYP=S

http://stockcharts.com/h-sc/ui?s=ngsx

11$ TGT ..We are at 3.70 which is a big joke

6$++ by end of this month

Load up the truck Folks before the stock gets discovered .

See my previous posting for more infos .

GL

NGSX is on the move

Buy with both hands there is no real resistance till $5 .

A lot of good news coming see my previous post .

I LOVE THIS LOW FLOAT STOCK.A SCREAMING MONSTER BUYING OPPORTUNITY !!

This undiscovered hot stock is trading below cash...Please Read

NGSX has a great product called Qutenza(Neuropathic pain) which is available on the Market in Europe and USA since mid 2010 .Qutenza sales could reach 300++Million per year .
sNDA submission for HIV-AN indication in 1H 2011.. FDA approval expected in 3Q 2011 .Qutenza has Blockbuster Potential in this new HIV indication .

Upcoming Major Milestones (click link):

http://www.wsw.com/webcast/roth24/ngsx/2__Slide24.JPG
sNDA submission in HIV-associated neuropathy to FDA in 1H 2011
Qutenza, which currently has U.S. orphan drug designation and fast track status, may be eligible for six-month priority review.

Asia/Latin America commercial partnership 1H 2011


Price Target: $15+ by year end


Neurogesx (NGSX)

Market Cap: 55.6 M
Cash: 57.7 M
Price: 3.13

Shares Out: 17.7 M
Float : ~ 4 M


Great article // A MUST READ !!!
http://www.dailyfinance.com/story/investing/inside-wall-street-this-little-phar ma-may-have-a-big-pain-relie/19450597/


http://www.wsw.com/webcast/roth24/ngsx/2__Slide19.JPG
http://www.wsw.com/webcast/roth24/ngsx/2__Slide4.JPG
http://www.wsw.com/webcast/roth24/ngsx/2__Slide17.JPG


Stephen Ghiglieri, EVP, COO and CFO, commented, "We are pleased with Qutenza market acceptance to date and continue to believe that our focused approach to the launch will provide the foundation to enable Qutenza to achieve its market potential. Our decision to move forward with the submission of an sNDA for Qutenza in HIV-AN is a positive step towards potential Qutenza label expansion that, if approved, could significantly expand Qutenza's addressable market. Re-entering the clinic with a Phase 2 study with NGX-1998 is also a significant step forward for this promising product candidate."

Clinical Pipeline Update:

Following a recent meeting with the U.S. Food and Drug Administration (FDA), NeurogesX announced plans to submit a supplemental new drug application (sNDA) for Qutenza in the first half of 2011 for the treatment of HIV-associated neuropathy (HIV-AN) also known as HIV–distal sensory polyneuropathy (HIV-DSP). The sNDA is excepted to be submitted with data from two completed Phase 3 studies in patients with HIV-AN. Qutenza, which currently has U.S. orphan drug designation and fast track status, may be eligible for six-month priority review.

IGXT hits 52w high ..Load up before its too late .

Great buying opp

Great buying opp

Another breakout is imminent

Still ver very cheap

Another breakout is imminent

Still very very cheap

Time to load up before the next jump coming

Time to load up before the nex jump coming

Anik is still one of the best and undervalued Bio stocks out there .Still a huge buying opportunity . glta

Anik is still one of the best and undervalued Bio stocks out there .Still a huge buying opportunity . glta

RAAALLLLYYYYYYYY BUT ITS JUST THE BEGINNING

EYE load up more igxt will be the next winner.

RALLLYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY

Load up the truck before it moves over 20$ . Anik awaiting 6 Approvals ENUFF said .

Major breakout on the way

Major Breakout on the way

DOUBLE DIGITS TODAY WOOOP

RALLLYYYYYYYYYYYYYYYYYYYYYYYYY

Load up before its too late ..Easy mony from here .GL

RALLLYYYYYYYYYYYYYYYYYYYYYY

LOAD UP BEFORE ITS TOO LATE ..GL

Anik is a big buying opportunity . Load up on the cheap while you still can . GL

There is really a lot of good news coming ..Anik will explode today !


Great Fourth Quarter Results
http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9Mzc0MzM4M3xDaGlsZElEPTQxNzQyMXxUeXBlPTI=&t=1

Anik is a big buying opportunity . Load up on the cheap while you still can . GL

There is really a lot of good news coming ..Anik will explode today !


Great Fourth Quarter Results
http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9Mzc0MzM4M3xDaGlsZElEPTQxNzQyMXxUeXBlPTI=&t=1

ANIK exploding after hour

Great results out .. Still a huge opportunity .GL

Anik exploding after hour

Great results out .. Still a huge opportunity .

Still a huge buying opportunity ..

5 Approvals pending

RALLLLYYYYYYYYYYYYYYYYYYYYYYY

IGXT will move up to ATH,if we break .63 . Anything below 1$ is a pure gift .Now is the best time to load up before the NDA resubmission news is out .GL


Resistance1: 0.6300
Resistance2: 0.7358

http://www.allotcbb.com/quote.php?symbol=igxt

Price and moving averages has closed above its Short term moving average. Short term moving average is above its mid-term; and above long term moving averages. From the relationship between price and moving averages; we can see that: this stock is BULLISH in short-term; and BULLISH in mid-long term.

Last chance to load up below 9$ ..

Last chance to load up below 9$

Great buying opportunity

GET IN NOW BEFORE THE STOCK GETS DISCOVERED !

Target: $4-5 within 6-8 Months .Please check it out its a real Winner !GL


Intelgenx (IGXT.OB)

Market Cap 22 Mio$
Price : 0,56 $

Shares Out : 33 M // Ceo holds 11 M Shares


Upcoming MAJOR Milestones 2011 :

Resubmit NDA for CPI-300 in 1Q11
Parnership for CPI-300 1H11
FDA approval for CPI-300 in 2H11


CPI-300 is a novel, high strength formulation of Bupropion hydrochloride ("HCl"), the active ingredient in Wellbutrin XL®. CPI-300 would be the only single pill, high strength, formulation of Bupropion hydrochloride on the market,sales could reach 300 Million$ per year !

Major Partnership for CPI-300 coming any time now which will bring big upfront payments to Intelgenx .

Intelgenx has a very attractive product pipeline (10 products) including a Blockbuster many of them nearing NDA filing.

GREAT BUYING OPPORTUNITY TODAY

LOAD UP WHILE ITS VERY CHEAP